Krishna Institute of Medical Sciences (KIMS) has raised approximately Rs.1,500 crore through a Qualified Institutions Placement (QIP), strengthening its growth and expansion plans. Shardul Amarchand Mangaldas & Co. acted as legal counsel, advising on the successful capital markets transaction.
Krishna Institute of Medical Sciences Limited (KIMS), a prominent healthcare corporate group in India, has raised approximately Rs. 1,500 crore (about USD 158 million) through a Qualified Institutions Placement (QIP).
The transaction was advised by Shardul Amarchand Mangaldas & Co.
The core transaction team included Prashant Gupta (Partner and National Practice Head – Capital Markets), Ruth Chenchiah (Partner), Ritika Khare (Principal Associate), Anoushka PV (Senior Associate), Anaya Jain (Associate), and Kunika Agarwal (Associate).
The QIP attracted participation from a broad range of institutional investors, including the International Finance Corporation (IFC), along with major mutual funds and insurance companies such as HSBC Mutual Fund, Edelweiss Mutual Fund, Axis Mutual Fund, ICICI Prudential Life Insurance, HDFC Life Insurance, and Kotak Mahindra Life Insurance.
The funds raised under the QIP are intended to be used for repayment and/or prepayment of certain outstanding borrowings taken by KIMS and certain of its subsidiaries.
Shardul Amarchand Mangaldas & Co. (SAM), built on more than a century of legal milestones, is one of India’s premier full-service law firms.
SAM’s mission is to support business growth by acting as trusted advisors, delivering solutions through excellence, responsiveness, innovation, and collaborative engagement.